"Pharmaceutical headlines" The State Drug Administration raided four arms companies were discontinued.

(2020/10/22) AstraZeneone's new crown vaccine Brazil trial of 1 patient deaths study has not been stopped; Tagg threw 900 million dollars a day into the new drug Kanglong cheng, Kailei Ying a crowd of CXO piles into the entry; Yale experts detailed "group immunity" vaccine is still the safest way ... (Click on the title, available in the original text) "Pharmaceutical 1st time" AstraZenecom new crown vaccine Brazil trial of a patient deaths study has not been called off recently, according to foreign media reports, in AstraZenelan's global COVID-19 vaccine phase III study, there was a case of subject death, affected by this news, AstraZeneta shares fell slightly.
relatively little detail about the death of one volunteer in the new crown vaccine trial.
the death was Brazilian, according to CNBC.
, it is not clear whether AstraZeneta's COVID-19 vaccine, AZD1222, is a fatal factor in the patient.
despite the deaths, the third phase of the trial in Brazil is now expected to continue.
: AstraZeneta has also tested the AZD1222 vaccine in India and South Africa.
on October 20, the State Drug Administration issued a notice on the flight inspection of four enterprises, including Qinghai Densta Medical Devices Co., Ltd., and found that the enterprise quality management system was mainly flawed, mainly related to institutions and personnel, production management, quality control, adverse event monitoring, analysis and improvement, equipment, design and development.
: Enterprises have confirmed the above-mentioned quality management system defects.
: Yale experts explain that "group immunity" vaccine is still the safest route Recently, the Journal of the American Medical Association (JAMA) published a review of "group immunity" from Yale's team of experts, article in the new crown pandemic In the context, several important indicators and factors affecting the immune effect of the population are explained, including the thresholds required to block transmission, the duration of protection, the characteristics of population exposure, the T-cell immune response, as well as the role of vaccines and the risk of natural infection.
: How long can group immunity be tubed? E drug manager: Tagg a day to throw 900 million into the new medicine Kanglong into, Kailaiying a group of CXO pile into more and more CXO industry companies began to extend to the pharmaceutical industry, in the form of LP through investment in early and medium-term pharmaceutical or medical companies, or direct equity investment, to participate in the domestic pharmaceutical innovation ecology to seek a piece of the pie.
October 20, Tiger Pharma issued six investment announcements in one breath, throwing 880 million yuan, this year Tiger Pharma has issued 15 related investment announcements, after a LP addiction.
headlines: Drug Mingkang performs a short-term deal for a perfect exit.
.